the benefits of glp-1 drugs beyond obesity Receptor Agonists and Research to Treat Overeating and Substance Use Disorders Can one drug do it

Apart from pancreatic islets, GIP and GLP-1 receptors have been identified in several other organs, including the intestine, heart, brain, and kidney

Hepatic cholesterol metabolism involves multiple parts, including cholesterol uptake, synthesis, biotransformation, and efflux

Available online: 18.Institute JBI

Its oral bioavailability is achieved by incorporating the absorption enhancer SNAC (Sodium N-[8-(2-hydroxybenzoyl)amino]caprylate), which works through two mechanisms: (1) temporarily raising the local pH in the stomach to reduce pepsin-induced degradation of the peptide drug, and (2) forming hydrophobic ion pairs (HIP) with the peptide drug, improving its membrane permeability

This is a big change for weight loss treatment